Graham Warren to Risk Assessment
This is a "connection" page, showing publications Graham Warren has written about Risk Assessment.
Connection Strength
0.213
-
Research Priorities, Measures, and Recommendations for Assessment of Tobacco Use in Clinical Cancer Research. Clin Cancer Res. 2016 Apr 15; 22(8):1907-13.
Score: 0.083
-
Tobacco assessment in actively accruing National Cancer Institute Cooperative Group Program Clinical Trials. J Clin Oncol. 2012 Aug 10; 30(23):2869-75.
Score: 0.065
-
Survival rates and prognostic factors for infiltrating salivary duct carcinoma: Analysis of 228 cases from the Surveillance, Epidemiology, and End Results database. Head Neck. 2014 May; 36(5):694-701.
Score: 0.018
-
Assessing tobacco use by cancer patients and facilitating cessation: an American Association for Cancer Research policy statement. Clin Cancer Res. 2013 Apr 15; 19(8):1941-8.
Score: 0.017
-
Association between thiazolidinedione treatment and risk of macular edema among patients with type 2 diabetes. Arch Intern Med. 2012 Jul 09; 172(13):1005-11.
Score: 0.016
-
Pretreatment nutritional status and locoregional failure of patients with head and neck cancer undergoing definitive concurrent chemoradiation therapy. Head Neck. 2011 Nov; 33(11):1561-8.
Score: 0.015